GC196 Minimally Invasive Thoracic Surgery
Minimally invasive thoracic surgery encompasses video-assisted thoracoscopic surgery (VATS) and robotic-assisted techniques that use small incisions and camera guidance to perform diagnostic and therapeutic procedures within the chest, reducing surgical trauma and recovery time compared to open thoracotomy.
This lecture by Dr. Sit Ko Yung (Cardiothoracic Surgery, QMH) is fundamentally about a philosophy, not just a technique. The core message is: Minimally invasive surgery (MIS) is not simply about making smaller incisions — it is a multimodal, multidisciplinary approach to minimize all forms of surgical trauma while achieving equivalent or superior outcomes. [1]
The lecture spans four big domains:
- What is surgical trauma and how does surgery harm patients? (the "why" behind MIS)
- How do you evaluate a new surgical technique? (evidence hierarchy from infancy → adulthood)
- Specific MIS innovations in thoracic surgery: VATS → Uniportal VATS → Non-intubated VATS → Robotic-assisted thoracic surgery (RATS)
- How to achieve early recovery: extent of lung resection (lobectomy vs sublobar), pain management, clinical pathways / Enhanced Recovery After Surgery (ERAS)
This is a conceptual and surgical-principles lecture. Examiners can test the philosophy, the advantages/disadvantages of each technique, key landmark trials (JCOG 0802, CALGB 140503), ERAS principles, and the clinical pathway of post-thoracic-surgery care.
1. The Concept of Minimally Invasive Surgery
High Yield — GC Lecture Definition
MIS is NOT just "smaller incision", "key hole surgery", or "robotic assisted surgery." These are components, but MIS is a holistic concept: minimize trauma / complications / side effects while achieving the same or better outcomes via a multimodal, multidisciplinary approach. [1]
This is a critical exam discriminator. If asked "What is minimally invasive surgery?", do NOT simply say "small incisions." The correct framework is:
| Common Misconception | Correct Understanding |
|---|---|
| MIS = smaller incision | MIS = minimize ALL forms of surgical trauma |
| MIS = keyhole surgery | MIS includes wound access, extent of resection, anaesthesia choices, clinical pathways, pain management |
| MIS = robotic surgery | Robotic surgery is one tool within the MIS philosophy |
Surgery simultaneously cures disease AND causes surgical trauma. [1] The goal of MIS is to maintain the curative intent while reducing the trauma component as much as possible.
The five sources of surgical trauma are: [1]
- GA & intubation
- Access (wound)
- Resected tissue
- Physiological derangement
- Psychological impact
Understanding each helps you understand why each MIS innovation exists:
| Trauma Component | Why It Matters | MIS Solution |
|---|---|---|
| GA & intubation | Double-lumen tube → airway injury, ventilator-associated injury, systemic inflammatory response | Non-intubated VATS (NIVATS) |
| Access wound | Larger incisions → more pain, intercostal nerve damage, longer recovery; "big surgeons make big incisions" was the old motto | VATS, Uniportal VATS, 3mm needlescopic instruments |
| Resected tissue | More tissue removed → worse post-op function (e.g. pneumonectomy vs lobectomy vs segmentectomy) | Sublobar resection / segmentectomy for appropriate tumours |
| Physiological | Stress response, inflammatory mediators, organ dysfunction | ERAS protocols, minimizing each trauma source |
| Psychological | Patient anxiety, fear, impact on QoL | Pre-operative counselling |
2.1 Side Effects of Cancer Surgery
Side effects specific to cancer surgery include: [1]
- Mortality
- Morbidity
- Adjuvant therapy (may be delayed if recovery is slow)
- Survival (compromised if oncological principles violated)
- Quality of Life (QoL)
This is why MIS for cancer must prove oncological equivalence — you cannot sacrifice cure for comfort.
The lecture presents a beautiful developmental framework for how any new surgical technique should be evaluated. This is a classic exam topic on surgical methodology/evidence-based surgery.
Four stages of evidence for a new surgical technique: [1]
| Stage | Name | What Is Demonstrated | Study Type |
|---|---|---|---|
| 1. Infancy | Safety & Feasibility | Can the operation be done without killing patients? Is it technically possible? | Case reports, small case series |
| 2. Childhood | Crude Benefit | Does it seem to help patients? (e.g. shorter stay, less blood loss) | Retrospective cohort, propensity-matched studies |
| 3. Adolescence | Objective, Quantifiable Benefit | Can we measure the benefit rigorously? (e.g. reduced complication rate, shorter drain duration) | Prospective studies, meta-analyses |
| 4. Adulthood | Treatment Efficacy | Does it achieve the same/better oncological outcomes? (overall survival, disease-free survival) | Randomized controlled trials (RCTs) |
Exam Trap
A common mistake is to accept a new technique based on "Childhood" or "Adolescence" data alone. The lecture emphasizes that you must reach "Adulthood" — i.e., demonstrate treatment efficacy via RCTs — before a technique can be considered standard of care.
4. Video-Assisted Thoracoscopic Surgery (VATS)
VATS replaced open thoracotomy (posterolateral thoracotomy with large incision, rib spreading, significant muscle division) with small port-site incisions and camera-assisted surgery. The evolution from "Past" (large open incisions) to "Present" (VATS) represents a paradigm shift.
Advantages of VATS: [1]
- Less post-operative pain
- Fast recovery
- Early discharge
- Less complication
- Less inflammatory response
- Same oncological outcome
The last point is crucial: VATS achieves the same oncological clearance (lymph node harvest, R0 resection rates, survival) as open thoracotomy for lung cancer — this satisfies the "Adulthood" evidence threshold.
4.3 Evolution: Minimizing Further
The lecture traces a clear progression to reduce wound trauma further:
Open Thoracotomy → Conventional VATS (3-4 ports) → 3mm Needlescopic VATS → Uniportal VATSFurther minimize wound using 3mm needlescopic instruments. [1]
These are ultra-thin instruments that reduce port-site trauma even within the conventional VATS framework.
High Yield — Uniportal VATS
Uniportal VATS minimizes access trauma by using only ONE intercostal space and nerve. This reduces pain and paraesthesia compared to multi-port VATS. [1]
Key principle: in multi-port VATS, each port traverses a different intercostal space → each intercostal nerve is potentially injured → more post-op pain / numbness. Uniportal VATS consolidates everything through a single incision.
Safety and Feasibility of Uniportal VATS:
- Utmost important for development of a new technique [1]
- Faced the same criticisms when conventional VATS first introduced [1] — i.e., concerns about safety, adequate oncological resection, and technical difficulty
Evidence for Uniportal VATS (from meta-analysis data on slides):
Compared to multi-port VATS, Uniportal VATS shows: [1]
Significant reduction in:
- Complication rate
- Hospital stay
- Chest drain duration
No difference in:
- Mortality
- OT time
- Blood loss
- Conversion rate
This places Uniportal VATS at the "Adolescence" stage — objective, quantifiable benefit demonstrated without compromise in safety.
5. Non-Intubated VATS (NIVATS)
Traditional thoracic surgery requires general anaesthesia with a double-lumen endotracheal tube for one-lung ventilation (the operative lung is deflated while the contralateral lung is ventilated). [1]
This carries specific harms:
- Airway injury from double-lumen tube placement
- Ventilator-induced lung injury (VILI)
- Systemic inflammatory response from mechanical ventilation
- Need for muscle relaxants (problematic in myasthenia gravis patients)
- Side effects of deep general anaesthesia
Non-intubated VATS technique: [1]
- Spontaneous breathing (the patient breathes on their own)
- Avoids airway injury
- Avoids mechanical ventilation
- Reduces systemic inflammatory response
- Dependent lung benefits: perfusion is better, lung recruitment is maintained by preserved diaphragmatic function, intrapulmonary shunt and hypoxaemia are reduced
- Regional/local anaesthesia (e.g. thoracic epidural, paravertebral block, intercostal nerve block)
- Avoids deep sedation
- Avoids muscle relaxant (especially important for myasthenia gravis patients undergoing thymectomy)
- Reduces side effects of GA
Why is the dependent lung physiology important?
During one-lung ventilation in the lateral position, the dependent (lower) lung is ventilated while the upper lung is collapsed. The problem: perfusion preferentially goes to the dependent lung (gravity), but it's also compressed by the mediastinum and abdomen. In NIVATS, the diaphragm continues to contract (spontaneous breathing), actively recruiting the dependent lung and improving V/Q matching. This reduces intrapulmonary shunt and hypoxaemia.
Applications include: [1]
- Pleural biopsy
- Lung wedge resection
- Sympathectomy
- Bullectomy
- Thymectomy
- Anatomical lung resection
- Segmentectomy
- Sleeve resection
- Carinal reconstruction
The range is impressively broad — NIVATS has moved well beyond simple diagnostic procedures to complex anatomical resections.
Non-intubated VATS: [1]
- Safe procedure
- Technically feasible
- Alternative for selected patients
- Early recovery demonstrated
- Long-term benefit unclear
This places NIVATS at the "Childhood" to early "Adolescence" stage of the evidence hierarchy.
6. Robotic-Assisted Thoracic Surgery (RATS)
Advantages of robotic-assisted surgery: [1]
- 10x magnified 3D view
- Camera stability
- 360° range of motion vs 47° for conventional instruments
- Seventh degree of freedom (the robotic wrist can articulate in ways the human hand through a port cannot)
- Improved dexterity
- Better ergonomics (surgeon sits at a console, reducing fatigue)
- Motion scaling (large hand movements translate to fine instrument movements)
- Filters hand tremor
Disadvantages: [1]
- Higher cost (startup and maintenance)
- Docking time (time to set up the robot adds to total OT time)
- Lack of tactile feedback (surgeon cannot "feel" tissue tension — must rely on visual cues)
The lecture specifically highlights thymectomy as a key application of RATS:
First reported robotic-assisted thymectomy: Yoshino et al., J Thorac Cardiovasc Surg 2001 [1]
Subxiphoid approach for robotic-assisted thymectomy is emphasized:
Advantages of subxiphoid approach: [1]
- Better visualize both phrenic nerves
- Better clearance of both cervical poles (important for complete thymectomy in myasthenia gravis)
- Less painful (avoids intercostal nerves entirely — the incision is below the xiphoid process)
- Enables reconstruction if necessary (e.g. vein and pericardium)
All procedures that can be done by VATS can be done by RATS. [1]
RATS vs VATS for lobectomy/segmentectomy (meta-analysis, Ma et al. BMC Cancer 2021):
18 studies, 11,247 patients (5,114 RATS vs 6,133 VATS): [1]
RATS showed:
- Less blood loss (p = 0.010)
- Lower conversion rate (p < 0.001)
- More harvested lymph nodes (p = 0.002)
- Shorter chest drain duration (p < 0.001)
- Shorter LOS (p < 0.001)
No significant difference in:
- Operative time, mortality, overall survival (OS), and disease-free survival
Exam Interpretation
RATS appears to offer incremental short-term benefits over VATS (less blood loss, more LN harvest, shorter stay), but no difference in long-term oncological outcomes (OS, DFS). The higher cost of robotics must be weighed against these marginal gains. The lecture's analogy: "Speed depends on Road, more than Car!" — meaning the clinical pathway and perioperative care matter more than the specific surgical platform. [1]
7. Extent of Lung Resection — Lobectomy vs Sublobar Resection
This section addresses the "resected tissue" component of surgical trauma.
Different lung resections (from most to least tissue removed): [1]
- Pneumonectomy — entire lung
- Lobectomy — one lobe
- Sublobar resection
- Segmentectomy — anatomical segment with its bronchus, artery, and vein
- Wedge resection — non-anatomical removal of a peripheral wedge of lung
Key milestones: [1]
- 1933: Graham performed the first pneumonectomy
- 1962: Cahan proposed "Radical lobectomy" (~30 years later)
- 1995: LCSG trial (Ginsberg RJ) — RCT of lobectomy vs limited resection for T1N0 NSCLC (~30 years later)
The 1995 LCSG trial showed lobectomy was superior to limited resection (higher local recurrence with limited resection). This established lobectomy as the gold standard for early-stage NSCLC for decades.
Background for segmentectomy: [1]
- Small-sized early-stage lung cancer is increasing (due to CT screening)
- Specific group of adenocarcinoma with low risk of nodal metastasis and recurrence
- Multiple synchronous primary lung cancers are increasing
- Limitations of the previous LCSG trial (small sample, older staging, no CT screening era tumours)
- Goals: Oncological clearance + Functional preservation
7.4 Landmark Trials: JCOG 0802 and CALGB 140503
These two RCTs are the most important recent evidence and are heavily emphasized in the lecture.
- Compared segmentectomy vs lobectomy for peripheral NSCLC ≤ 2cm
- Results: Segmentectomy was non-inferior to lobectomy for overall survival [1]
- Additionally showed better post-operative lung function preservation with segmentectomy
- Compared sublobar resection (segmentectomy or wedge) vs lobectomy for peripheral NSCLC ≤ 2cm
- Published in N Engl J Med 2023; 388:489-498 [1]
- Results: Sublobar resection was non-inferior to lobectomy for disease-free survival and overall survival
High Yield — Combined Trial Conclusion
JCOG 0802 + CALGB 140503: Sublobar resection can be considered for NSCLC patients with small peripheral tumors. Non-inferior results. [1]
This is a paradigm shift: for peripheral NSCLC ≤ 2cm, sublobar resection (particularly segmentectomy) is now an acceptable alternative to lobectomy, preserving more lung parenchyma and improving post-operative lung function.
| Feature | JCOG 0802 | CALGB 140503 |
|---|---|---|
| Population | Peripheral NSCLC ≤ 2cm | Peripheral NSCLC ≤ 2cm |
| Comparison | Segmentectomy vs Lobectomy | Sublobar (segmentectomy or wedge) vs Lobectomy |
| Primary endpoint | Overall survival | Disease-free survival |
| Result | Non-inferior | Non-inferior |
| Key benefit | Lung function preservation | Lung function preservation |
Approaches to reduce post-op pain: [1]
| Timing | Strategy |
|---|---|
| Pre-operative | Pre-operative counselling — managing expectations reduces pain perception |
| Intra-operative | Pre-emptive local anaesthetic (LA), Paravertebral block, Intercostal nerve block |
| Post-operative | Post-op protocol — multimodal analgesia (IV PCA → oral analgesia), physiotherapy |
The lecture emphasizes that pain management is multimodal — not just pharmacological but also involves surgical technique (smaller incisions, fewer ports), anaesthetic technique (regional blocks), and post-op protocols.
The lecture includes a detailed day-by-day clinical pathway. This is extremely high-yield for ward management questions.
| Day | Goals | Key Actions |
|---|---|---|
| Pre-op | Ensure patient prepared for OT; anticipate post-op needs | Height/Weight, baseline vitals, sputum C/ST + AFB, ensure CXR/CT/FEV1 available, pre-admission meds (stop Aspirin/Plavix), chest physio training, Triflow purchase, consent, SFI payment |
| Day 0 | Intensive monitoring for post-op complications | Q1H vitals ×6h → Q4H; CD chart Q1H → Q4H; CD to suction, IV fluids, IV antibiotics, IV PCA, oral analgesia on DAT; CXR on suction; sit up as tolerated; begin Triflow |
| Day 1 | Ensure safety & comfort; ensure early mobilization | Off O2, off CD suction, off PCA, off IV fluids; resume Aspirin/Plavix; post-op chest physio; CXR after off suction; sit out all day, mobilize; Triflow 10× per 30 mins |
| Day 2 | Remove chest drain | Off CD if: no air leak AND output ≤ 200 mL/day; wound review; CXR after CD removal; change dressings; adequate analgesia |
| Day 3 | Comfort & recovery | Continue mobilization, Triflow, analgesia, chest physio |
| Day 4-5 | Discharge if safe & home/family ready | CXR, change dressings pre-discharge; ensure patient mobile & independent; discharge summary, drugs, sick leave; f/u SOPD 1/52 + CXR |
| Day 6+ | Manage any cause of prolonged stay | If CD not yet removed: chemical pleurodesis if air leak; change CD box every 7 days; change dressings every 3-4 days |
Key Discharge Criteria for Chest Drain Removal
Chest drain removal criteria: [1]
- No air leak (no bubbling in the underwater seal)
- Output ≤ 200 mL/day
- CXR shows lung re-expanded
9.1 VATS Clinical Pathway Components
The standardized pathway includes: [1]
- Investigations algorithm
- Air leak management
- Wound care protocol
- Chest drain documentation
- Mobilization schedule
- Analgesic strategies
- Regular communication
- VATS physiotherapy
High Yield — ERAS Definition
Enhanced Recovery After Surgery (ERAS) = "Fast track surgery" = a multimodal, multidisciplinary perioperative care pathway for surgical patients [1]
Goals:
- Improved quality of care (reduced complications, hospital stay, readmissions)
- Reduced healthcare costs
- Increased patient and staff satisfaction
ERAS brings together everything in this lecture: MIS techniques, pain management, early mobilization, standardized pathways, and patient education.
Summary of MIS Strategies for Thoracic Surgery
Minimize surgical trauma through: [1]
- Pre-op counselling
- Pain management
- Size of wound (VATS → Uniportal → Needlescopic)
- Number of incisions (Multi-port → Uniportal)
- Extent of surgical resection (Pneumonectomy → Lobectomy → Segmentectomy)
- Anaesthesia (GA with DLT → Non-intubated)
- Clinical pathway (ERAS)
Results in: Early recovery, better surgical outcomes, patient satisfaction, wider range of surgical candidates [1]
"…but not 'No morbidity'" [1]
MIS does NOT eliminate morbidity entirely. Complications still occur. The aim is to reduce them, not eliminate them. This is an important point for counselling patients and for exam answers.
12. Integration with Related Material
The MIS approach applies equally to oesophagectomy. As covered in GC 189, approaches include Open, VATS, Total MIE (minimally invasive oesophagectomy), and Robotic. QMH performs 80-90% of oesophagectomies as total MIE. [2] The same principles apply: reduced wound trauma, equivalent oncological outcomes, faster recovery.
Cardiac surgery similarly uses MIS approaches: paramedian approach, hemisternotomy, thoracotomy approach, and robotic-assisted approach for valvular surgery. [3] The principle is the same — median sternotomy requires 10 weeks for bone healing and carries wound infection risk; MIS approaches reduce this.
The broader categories of MIS in surgery include: laparoscopic, robotic, endoscopic, NOTES (Natural Orifice Transluminal Endoscopic Surgery), and endovascular. [4] Thoracic MIS fits within this larger framework.
Post-VATS chest drain management follows standard principles: insertion in the safety triangle (5th ICS, bordered by pectoralis major laterally and latissimus dorsi anteriorly), underwater seal with 2cm H₂O, monitoring for swinging and bubbling. [5]
Exam Intelligence
| Theme | What Examiners Want |
|---|---|
| Definition of MIS | NOT just small incisions — multimodal approach to minimize ALL trauma |
| Advantages of VATS | The 6-point list: less pain, fast recovery, early discharge, less complication, less inflammatory response, same oncological outcome |
| Uniportal vs Multi-port | Uniportal = one intercostal nerve = less pain/paraesthesia; evidence shows reduced complications, hospital stay, drain duration with no difference in mortality or conversion |
| RATS advantages/disadvantages | 3D view, 7 DOF, tremor filter, motion scaling vs cost, docking time, no tactile feedback |
| NIVATS | Avoids intubation harms, good for MG patients, spontaneous breathing maintains diaphragm function and reduces shunt |
| Sublobar resection evidence | JCOG 0802 + CALGB 140503: for peripheral NSCLC ≤ 2cm, sublobar resection non-inferior to lobectomy |
| Chest drain removal criteria | No air leak + output ≤ 200 mL/day |
| ERAS | Multimodal, multidisciplinary perioperative pathway; reduced complications, LOS, readmissions, costs |
| Evidence hierarchy | Infancy → Childhood → Adolescence → Adulthood |
| If Asked About... | Correct Answer | Common Trap |
|---|---|---|
| "Main advantage of uniportal VATS" | Only one intercostal nerve affected → less pain | "Faster surgery" (OT time is not significantly different) |
| "Why NIVATS for myasthenia gravis" | Avoids muscle relaxants | "Avoids intubation" (true but not the MG-specific reason) |
| "RATS vs VATS oncological outcome" | No difference in OS or DFS | Thinking RATS is "better" because of more LN harvest |
| "Indication for segmentectomy" | Peripheral NSCLC ≤ 2cm, specific adenocarcinoma subtypes | Applying it to all lung cancers regardless of size/location |
| "Disadvantage of pneumonectomy" | Maximum loss of lung parenchyma → worst post-op function | Forgetting that mortality is also higher |
Past Paper Questions
"List three advantages of minimally invasive surgery." (6 marks) [6]
Markscheme answer (based on this lecture):
- Less post-operative pain (reduced wound trauma, fewer intercostal nerves injured)
- Faster recovery / early discharge (shorter hospital stay)
- Fewer post-operative complications (less inflammatory response, less wound infection)
Additional acceptable answers: better cosmesis, reduced blood loss, same oncological outcome (for cancer surgery), reduced healthcare costs.
Discriminator: The question asks for "advantages," not "definition." You should list concrete benefits, not describe the philosophy. Each advantage should be a distinct point — "faster recovery" and "early discharge" can count as one if the examiner is strict, so include "less pain" and "fewer complications" as separate items.
"An 89-year-old gentleman undergoes laparoscopic cholecystectomy under GA. He develops hypotension right after the surgeon insufflates the peritoneal cavity with CO₂. Which of the following is a physiological effect of pneumoperitoneum?" [7]
A. Decrease in airway resistance B. Decrease in functional residual capacity ✓ C. Increase in renal perfusion D. Increase in venous return
Rationale: This is a general MIS/laparoscopic surgery question. CO₂ pneumoperitoneum increases intra-abdominal pressure → diaphragm pushed up → decreased FRC and pulmonary compliance. It also causes decreased venous return (IVC compression initially), decreased renal perfusion, and increased airway resistance. The immediate hypotension is from IVC compression reducing venous return (but D says "increase" so it's wrong).
Connection to this lecture: The same MIS principles apply — understanding the physiological consequences of the surgical approach is part of comprehensive MIS knowledge.
High Yield Summary
Minimally Invasive Thoracic Surgery — Key Takeaways:
-
MIS ≠ small incisions. It is a multimodal, multidisciplinary approach to minimize ALL surgical trauma (GA/intubation, access wound, resected tissue, physiological, psychological).
-
VATS advantages (memorize): Less pain, fast recovery, early discharge, fewer complications, less inflammatory response, same oncological outcome.
-
Uniportal VATS: One intercostal space → one nerve → less pain/paraesthesia. Evidence: reduced complications, shorter stay and drain duration; no difference in mortality or conversion rate.
-
NIVATS: Spontaneous breathing avoids intubation-related harm. Key for MG patients (avoids muscle relaxants). Preserves diaphragmatic function → better V/Q matching.
-
RATS advantages: 3D, 360° motion, 7 DOF, tremor filter, motion scaling. Disadvantages: cost, docking time, no tactile feedback. RATS vs VATS: no difference in OS/DFS.
-
Sublobar resection now acceptable for peripheral NSCLC ≤ 2cm (JCOG 0802 + CALGB 140503). Non-inferior to lobectomy for DFS and OS.
-
Chest drain removal: No air leak + output ≤ 200 mL/day.
-
ERAS: Multimodal, multidisciplinary perioperative pathway → reduced complications, LOS, readmissions, and costs.
-
Evidence hierarchy for new techniques: Infancy (safety/feasibility) → Childhood (crude benefit) → Adolescence (quantifiable benefit) → Adulthood (treatment efficacy via RCT).
-
The lecture's parting message: "To improve is to change; to be perfect is to change often." — Interrogate, Investigate, Integrate.
Active Recall - Minimally Invasive Thoracic Surgery
[1] Lecture slides: GC 196. Minimally Invasive Thoracic Surgery.pdf [2] Lecture slides: GC 189. I can't swallow oesophageal cancer.pdf [3] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Cardiothoracic diseases section) [4] Lecture slides: 2022 07 29 Surgery Surgical Principles (Dr IYH Wong).pdf [5] Senior notes: Maksim Medicine Notes.pdf (Chest drain section) [6] Past papers: 2021 Fourth Summative Minicase.pdf (Case 2, Q12) [7] Past papers: 2022 Fourth Summative MCQ.pdf (Q63)
GC195 Lower And Diffuse Abdominal Pain RLQ Problems; Pelvic Inflammatory Disease; Peritonitis And Abdominal Emergencies
Lower and diffuse abdominal pain encompasses right lower quadrant pathologies such as appendicitis, pelvic inflammatory disease caused by ascending genital tract infection, and peritonitis resulting from inflammation of the peritoneal cavity, all of which may present as acute abdominal emergencies requiring urgent evaluation and management.
GC198 Profuse Vomiting Of Fresh Blood And In Shock Severe Upper GI Bleeding
Severe upper gastrointestinal hemorrhage presenting with large-volume hematemesis of fresh (bright red) blood accompanied by hemodynamic shock requiring emergent resuscitation and intervention.